DecImmune Therapeutics Inc

Decimmune Therapeutics, Inc. operates as a biotechnology company. The Company develops and provides monoclonal antibody medicines which prevents tissue damage, preserves organ function, and treats vascular inflammatory diseases. Decimmune Therapeutics serves customers in the United States.